MYCN amplification, activating mutations in the ALK receptor tyrosine kinase, TERT rearrangements, inactivating ATRX mutations and dominant negative mutations in PHOX2B are among the most recurrent genetic events that drive oncogenic signaling and tumor formation23,25,27,51–54. The gene discussed is NTRK1; the disease is neoplasm.